These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19646561)

  • 21. Discussion: 'Testing for biomarkers after ASC-US Pap smears' by Lin et al.
    Macones GA; Odibo A; Cahill A; Stamilio D
    Am J Obstet Gynecol; 2011 Jan; 204(1):e12-3. PubMed ID: 21187191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [GnRH agonist and add back therapy--indications, results and problems in the treatment of genital endometriosis].
    Mettler L
    Zentralbl Gynakol; 2003; 125(7-8):267-75. PubMed ID: 14505262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premenstrual syndrome--pathophysiologic considerations.
    Mortola JF
    N Engl J Med; 1998 Jan; 338(4):256-7. PubMed ID: 9435333
    [No Abstract]   [Full Text] [Related]  

  • 24. Reproductive factors associated with nocturia and urgency: Tikkinen et al.
    Allsworth JE; Omicioli VA; Cunkelman JA; Homco J
    Am J Obstet Gynecol; 2008 Aug; 199(2):205-6. PubMed ID: 18674664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant therapy during the administration of GnRH agonists].
    Nikolov A; Kolarov G
    Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
    [No Abstract]   [Full Text] [Related]  

  • 26. Progesterone organogel for premenstrual dysphoric disorder.
    Schaller JL; Briggs B; Briggs M
    J Am Acad Child Adolesc Psychiatry; 2000 May; 39(5):546-7. PubMed ID: 10802970
    [No Abstract]   [Full Text] [Related]  

  • 27. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone organogel for premenstrual dysphoric disorder.
    Capps S
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):261. PubMed ID: 11288763
    [No Abstract]   [Full Text] [Related]  

  • 29. Premenstrual syndrome: current perspectives on treatment and etiology.
    Freeman EW
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):147-53. PubMed ID: 9263696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of gonadotropin-releasing hormone analogues in the treatment of premenstrual syndrome.
    Mortola JF
    Clin Obstet Gynecol; 1993 Sep; 36(3):753-63. PubMed ID: 8403622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug therapy of ovarian cysts].
    Schindler AE
    Zentralbl Gynakol; 1994; 116(11):619-21. PubMed ID: 7871912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The premenstrual syndrome.
    Watson NR; Studd JW
    Br J Hosp Med; 1990 Oct; 44(4):286-92. PubMed ID: 2249107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of premenstrual disorders by suppression of ovulation by transdermal estrogens.
    Studd J
    Menopause Int; 2012 Jun; 18(2):65-7. PubMed ID: 22611224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term gonadotrophin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms.
    Adashi EY
    Hum Reprod; 1994 Jul; 9(7):1380-97. PubMed ID: 7962453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The premenstrual syndrome. A survey of current treatment practices.
    Lyon KE; Lyon MA
    J Reprod Med; 1984 Oct; 29(10):705-11. PubMed ID: 6542591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premenstrual syndrome.
    DeMonico SO; Brown CS; Ling FW
    Curr Opin Obstet Gynecol; 1994 Dec; 6(6):499-502. PubMed ID: 7893953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discussion: 'Perioperative morbidity model for vaginal hysterectomy' by Heisler et al.
    Zighelboim I; Zhang C; Kuroki L; Anand M; Dewdney S
    Am J Obstet Gynecol; 2010 Feb; 202(2):e1-3. PubMed ID: 20113684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms.
    Adashi EY
    Keio J Med; 1995 Dec; 44(4):124-32. PubMed ID: 8587224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient.
    Surrey ES
    Fertil Steril; 1995 Oct; 64(4):673-85. PubMed ID: 7672133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discussion: 'Infant death among Ohio residents' by Donovan et al.
    Tita AT; Wetta LA; Bates E; Doss A; Erwin JL
    Am J Obstet Gynecol; 2010 Jul; 203(1):e8-9. PubMed ID: 20609699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.